Literature DB >> 18691352

Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.

M Lemoine1, S Katsahian, M Ziol, P Nahon, N Ganne-Carrie, F Kazemi, V Grando-Lemaire, J-C Trinchet, M Beaugrand.   

Abstract

BACKGROUND: Hepatic venous pressure gradient (HVPG) is the gold standard for assessing the presence and the severity of portal hypertension (PHT). Liver stiffness measurement (LSM) is a non-invasive method for liver fibrosis assessment. AIMS: To assess the relationship between LSM and HVPG in patients with compensated cirrhosis related to hepatitis C virus (HCV) or alcohol and to define the performance and the best cut-off of LSM for the diagnosis of PHT in these patients.
METHODS: Between January 2004 and September 2006, we studied all the consecutive patients with compensated HCV or alcohol-related-cirrhosis referred for transjugular liver biopsy with HVPG measurement and LSM performed the same day.
RESULTS: Ninety-two patients were eligible, 44 had HCV related-cirrhosis and 48 alcoholic cirrhosis. LSM was positively correlated to HVPG in both groups. The area under the receiver operating characteristic curve for the diagnosis of significant PHT was 0.76 +/- 0.07 in HCV patients (best cut-off at 20.5 kPa) and 0.94 +/- 0.03 (best cut-off at 34.9 kPa) in alcoholic patients.
CONCLUSIONS: Liver stiffness measurement and HVPG were significantly correlated in patients with compensated cirrhosis because of HCV infection or alcohol. LSM could predict significant PHT in both these groups of patients with a higher cut-off and a better performance in alcoholic patients.

Entities:  

Mesh:

Year:  2008        PMID: 18691352     DOI: 10.1111/j.1365-2036.2008.03825.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  53 in total

Review 1.  Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan(®)).

Authors:  Monica Lupsor-Platon; Radu Badea
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 2.  Four-dimensional flow magnetic resonance imaging in cirrhosis.

Authors:  Zoran Stankovic
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 3.  Critical comparison of elastography methods to assess chronic liver disease.

Authors:  Mireen Friedrich-Rust; Thierry Poynard; Laurent Castera
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

Review 4.  Invasive and non-invasive diagnosis of cirrhosis and portal hypertension.

Authors:  Moon Young Kim; Woo Kyoung Jeong; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

5.  Clinical role of non-invasive assessment of portal hypertension.

Authors:  Massimo Bolognesi; Marco Di Pascoli; David Sacerdoti
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

6.  Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis.

Authors:  Jinzhen Song; Zida Ma; Jianbo Huang; Shiyu Liu; Yan Luo; Qiang Lu; Philipp Schwabl; Romanas Zykus; Ashish Kumar; Matthew Kitson
Journal:  Eur Radiol       Date:  2018-06-01       Impact factor: 5.315

Review 7.  Natural history of cirrhosis.

Authors:  Sumeet K Asrani; Patrick S Kamath
Journal:  Curr Gastroenterol Rep       Date:  2013-02

Review 8.  Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives.

Authors:  Beom Kyung Kim; James Fung; Man-Fung Yuen; Seung Up Kim
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

Review 9.  Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV.

Authors:  Bassem Matta; Tzu-Hao Lee; Keyur Patel
Journal:  Curr HIV/AIDS Rep       Date:  2016-10       Impact factor: 5.071

10.  Noninvasive Assessment of Fibrosis Regression in Hepatitis C Virus Sustained Virologic Responders.

Authors:  Hirsh D Trivedi; Steven C Lin; Daryl T Y Lau
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.